Cargando…

Wnt/beta-catenin pathway: modulating anticancer immune response

Wnt/β-catenin signaling, a highly conserved pathway through evolution, regulates key cellular functions including proliferation, differentiation, migration, genetic stability, apoptosis, and stem cell renewal. The Wnt pathway mediates biological processes by a canonical or noncanonical pathway, depe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Sachin Gopalkrishna, Carneiro, Benedito A., Mota, Jose Mauricio, Costa, Ricardo, Leite, Caio Abner, Barroso-Sousa, Romualdo, Kaplan, Jason Benjamin, Chae, Young Kwang, Giles, Francis Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420131/
https://www.ncbi.nlm.nih.gov/pubmed/28476164
http://dx.doi.org/10.1186/s13045-017-0471-6
_version_ 1783234352085204992
author Pai, Sachin Gopalkrishna
Carneiro, Benedito A.
Mota, Jose Mauricio
Costa, Ricardo
Leite, Caio Abner
Barroso-Sousa, Romualdo
Kaplan, Jason Benjamin
Chae, Young Kwang
Giles, Francis Joseph
author_facet Pai, Sachin Gopalkrishna
Carneiro, Benedito A.
Mota, Jose Mauricio
Costa, Ricardo
Leite, Caio Abner
Barroso-Sousa, Romualdo
Kaplan, Jason Benjamin
Chae, Young Kwang
Giles, Francis Joseph
author_sort Pai, Sachin Gopalkrishna
collection PubMed
description Wnt/β-catenin signaling, a highly conserved pathway through evolution, regulates key cellular functions including proliferation, differentiation, migration, genetic stability, apoptosis, and stem cell renewal. The Wnt pathway mediates biological processes by a canonical or noncanonical pathway, depending on the involvement of β-catenin in signal transduction. β-catenin is a core component of the cadherin protein complex, whose stabilization is essential for the activation of Wnt/β-catenin signaling. As multiple aberrations in this pathway occur in numerous cancers, WNT-directed therapy represents an area of significant developmental therapeutics focus. The recently described role of Wnt/β-catenin pathway in regulating immune cell infiltration of the tumor microenvironment renewed the interest, given its potential impact on responses to immunotherapy treatments. This article summarizes the role of Wnt/β-catenin pathway in cancer and ongoing therapeutic strategies involving this pathway.
format Online
Article
Text
id pubmed-5420131
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54201312017-05-08 Wnt/beta-catenin pathway: modulating anticancer immune response Pai, Sachin Gopalkrishna Carneiro, Benedito A. Mota, Jose Mauricio Costa, Ricardo Leite, Caio Abner Barroso-Sousa, Romualdo Kaplan, Jason Benjamin Chae, Young Kwang Giles, Francis Joseph J Hematol Oncol Review Wnt/β-catenin signaling, a highly conserved pathway through evolution, regulates key cellular functions including proliferation, differentiation, migration, genetic stability, apoptosis, and stem cell renewal. The Wnt pathway mediates biological processes by a canonical or noncanonical pathway, depending on the involvement of β-catenin in signal transduction. β-catenin is a core component of the cadherin protein complex, whose stabilization is essential for the activation of Wnt/β-catenin signaling. As multiple aberrations in this pathway occur in numerous cancers, WNT-directed therapy represents an area of significant developmental therapeutics focus. The recently described role of Wnt/β-catenin pathway in regulating immune cell infiltration of the tumor microenvironment renewed the interest, given its potential impact on responses to immunotherapy treatments. This article summarizes the role of Wnt/β-catenin pathway in cancer and ongoing therapeutic strategies involving this pathway. BioMed Central 2017-05-05 /pmc/articles/PMC5420131/ /pubmed/28476164 http://dx.doi.org/10.1186/s13045-017-0471-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Pai, Sachin Gopalkrishna
Carneiro, Benedito A.
Mota, Jose Mauricio
Costa, Ricardo
Leite, Caio Abner
Barroso-Sousa, Romualdo
Kaplan, Jason Benjamin
Chae, Young Kwang
Giles, Francis Joseph
Wnt/beta-catenin pathway: modulating anticancer immune response
title Wnt/beta-catenin pathway: modulating anticancer immune response
title_full Wnt/beta-catenin pathway: modulating anticancer immune response
title_fullStr Wnt/beta-catenin pathway: modulating anticancer immune response
title_full_unstemmed Wnt/beta-catenin pathway: modulating anticancer immune response
title_short Wnt/beta-catenin pathway: modulating anticancer immune response
title_sort wnt/beta-catenin pathway: modulating anticancer immune response
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420131/
https://www.ncbi.nlm.nih.gov/pubmed/28476164
http://dx.doi.org/10.1186/s13045-017-0471-6
work_keys_str_mv AT paisachingopalkrishna wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT carneirobeneditoa wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT motajosemauricio wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT costaricardo wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT leitecaioabner wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT barrososousaromualdo wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT kaplanjasonbenjamin wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT chaeyoungkwang wntbetacateninpathwaymodulatinganticancerimmuneresponse
AT gilesfrancisjoseph wntbetacateninpathwaymodulatinganticancerimmuneresponse